IMR Press / CEOG / Volume 45 / Issue 6 / DOI: 10.12891/ceog4472.2018

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Unintended pregnancies with term delivery following ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation of uterine fibroid and adenomyosis
Show Less
1 Aegis-Roen Obstetrics and Gynecology Clinic, Seoul, Korea
2 Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, Korea
3 Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea
Clin. Exp. Obstet. Gynecol. 2018, 45(6), 842–844;
Published: 10 December 2018

Purpose of Investigation: This study aimed to assess the pregnancy outcome of patients with uterine fibroid or adenomyosis treated by ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation. Materials and Methods: Treatment was administrated using a focused ultrasound tumor therapeutic system. In this study, there were 23 unintended pregnancies after USgHIFU ablation. Results: Twelve patients developed no complication during pregnancy and continued until full term delivery. Vaginal and cesarean section deliveries were also uneventful. The following are the pregnancy outcome of the patients: three patients experienced spontaneous abortions, one patient experienced preterm delivery, and five patients remained pregnant at this point. Conclusions: USgHIFU seems to have the effectiveness to precisely treat adenomyosis and uterine fibroid, allowing for normal reproduction. Well-designed prospective trials are needed to ascertain the safety of this treatment with pregnancy due to the lack of large-scaled study.
Uterine fibroid
Back to top